PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


Growth in 3 years

Total Asset Growth
26.45%

Total Liabilities growth
9.50%

Reserves Change
-6.41%



Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

MF Holdings

Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.

Scheme Name AUM (%) CMV ( in Cr.) Holding Date
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
View More

News

Stay tuned to the latest developments and happenings in the company.

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as against Rs 194.10 crore during the previous quarter en....

06 Aug 2024 17:16

USFDA conducts surprise inspection of Gland Pharma`s Dundigal facility

Gland Pharma announced that the United States Food and Drug Administration (US FDA) has conducted surprise inspection of the Company`s Dundigal Facili....

25 Jul 2024 13:49

Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic S....

24 Jul 2024 10:09

Gland Pharma schedules board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live News

20 Jul 2024 12:06

Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter

Net profit of Gland Pharma rose 144.56% to Rs 192.42 crore in the quarter ended March 2024 as against Rs 78.68 crore during the previous quarter ended....

23 May 2024 07:36

Gland Pharma consolidated net profit declines 17.28% in the December 2023 quarter

Net profit of Gland Pharma declined 17.28% to Rs 191.86 crore in the quarter ended December 2023 as against Rs 231.95 crore during the previous quarte....

14 Feb 2024 17:22

View More
Subscribe for our
newsletter
Open Account Now